NMPA Approval

Lopinavir and Ritonavir Tablets

Approval Number

国药准字H20247241

Company上海迪赛诺医药集团股份有限公司

Registration Date

October 14, 2024

Previous Approval Numbers

国药准字H20233907

Drug Information

Generic Name

洛匹那韦利托那韦片

Dosage Form

片剂

Strength

每片含洛匹那韦100mg，利托那韦25mg

Drug Type

化学药品

Registration Date

October 14, 2024

Company Information

Applicant Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号1幢

Manufacturing Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.